Venus Remedies Ltd Sees Technical Momentum Shift Amid Mixed Signals

Technical Trend Overview and Price Movement

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, currently trades at ₹724.00, down 4.20% from the previous close of ₹755.75. The stock’s intraday range on 21 Jan 2026 spanned from ₹718.00 to ₹769.00, indicating some volatility amid broader market pressures. Over the past week and month, the stock has underperformed the Sensex, with returns of -2.75% and -6.24% respectively, compared to the Sensex’s -1.73% and -3.24%. Year-to-date, Venus Remedies has declined by 5.61%, lagging the Sensex’s 3.57% fall.

However, the longer-term performance remains robust. Over one year, the stock has surged 144.43%, vastly outperforming the Sensex’s 6.63% gain. The three-year and five-year returns stand at 348.44% and 341.73%, dwarfing the Sensex’s 35.56% and 65.05% respectively. Impressively, the ten-year return is 659.71%, nearly triple the Sensex’s 241.54%, underscoring the company’s sustained growth trajectory despite recent technical softness.

Mixed Technical Indicator Signals

The technical landscape for Venus Remedies is complex. The Moving Average Convergence Divergence (MACD) remains bullish on both weekly and monthly charts, signalling underlying positive momentum. The weekly MACD suggests continued buying interest, while the monthly MACD confirms a longer-term uptrend.

Conversely, the Relative Strength Index (RSI) presents a mixed picture. The weekly RSI currently shows no clear signal, hovering in a neutral zone that neither indicates overbought nor oversold conditions. Meanwhile, the monthly RSI has turned bearish, suggesting some weakening in momentum over the longer term. This divergence between weekly and monthly RSI readings points to a potential consolidation phase or a pause in the stock’s upward momentum.

Bollinger Bands on both weekly and monthly timeframes are mildly bullish, indicating that price volatility remains contained within an upward trending channel. The daily moving averages also support a mildly bullish stance, with short-term averages positioned above longer-term averages, albeit with less conviction than in previous months.

Additional Technical Measures and Trend Assessments

The Know Sure Thing (KST) indicator aligns with the MACD, showing bullish signals on both weekly and monthly charts. This reinforces the notion that despite recent price dips, the stock retains positive momentum drivers.

However, Dow Theory analysis reveals no definitive trend on weekly or monthly scales, reflecting uncertainty in market direction. Similarly, On-Balance Volume (OBV) indicators show no clear trend, suggesting that volume flows have not decisively favoured buyers or sellers in recent sessions.

Mojo Score and Grade Revision

Venus Remedies’ Mojo Score currently stands at 72.0, categorised as a Buy grade. This represents a downgrade from a Strong Buy rating assigned on 20 Jan 2026. The adjustment reflects the tempered technical momentum and recent price weakness, signalling a more cautious outlook among technical analysts. The company’s Market Cap Grade remains at 4, indicating a mid-sized market capitalisation within its sector.

Price Momentum and Moving Averages Analysis

The daily moving averages for Venus Remedies indicate a mildly bullish trend, with the 50-day moving average currently positioned slightly above the 200-day moving average. This “golden cross” formation, although not strongly pronounced, suggests that the stock may be poised for gradual upward movement if supported by volume and broader market conditions.

Price momentum, however, has softened as reflected in the recent 4.20% decline on 21 Jan 2026. The stock’s inability to sustain levels above ₹755.75 and the retreat from the 52-week high of ₹848.90 highlight resistance challenges. The 52-week low remains at ₹272.20, underscoring the stock’s wide trading range and volatility over the past year.

Sector and Industry Context

Within the Pharmaceuticals & Biotechnology sector, Venus Remedies continues to hold a competitive position. The sector has faced mixed headwinds recently, including regulatory scrutiny and supply chain disruptions, which have impacted valuations and investor sentiment. Venus Remedies’ technical indicators suggest it is navigating these challenges with relative resilience, though the downgrade in momentum signals caution.

Long-Term Investment Perspective

Despite short-term technical fluctuations, Venus Remedies’ long-term returns remain impressive. The stock’s 10-year return of 659.71% far exceeds the Sensex’s 241.54%, reflecting strong fundamentals and growth prospects. Investors with a longer horizon may view the current technical softness as a potential entry point, provided the company maintains its operational performance and sector tailwinds.

Investor Takeaway

Venus Remedies Ltd’s recent technical parameter changes reflect a transition to a more cautious, mildly bullish stance. While key momentum indicators such as MACD and KST remain positive, the bearish monthly RSI and lack of clear volume trends suggest investors should monitor price action closely. The downgrade from Strong Buy to Buy in the Mojo Grade signals tempered enthusiasm, though the company’s long-term growth story remains intact.

Investors should weigh the current technical signals alongside fundamental factors and sector dynamics before making allocation decisions. The stock’s strong historical returns and sector positioning offer upside potential, but near-term volatility and resistance levels warrant prudence.

Summary of Technical Indicators for Venus Remedies Ltd

• MACD: Weekly and Monthly - Bullish


• RSI: Weekly - Neutral; Monthly - Bearish


• Bollinger Bands: Weekly and Monthly - Mildly Bullish


• Moving Averages (Daily): Mildly Bullish


• KST: Weekly and Monthly - Bullish


• Dow Theory: Weekly and Monthly - No Trend


• OBV: Weekly and Monthly - No Trend

Overall, Venus Remedies Ltd remains a stock with strong underlying momentum tempered by recent technical caution. Market participants should continue to analyse evolving price patterns and volume dynamics to gauge the next directional move.

Unlock special upgrade rates for a limited period. Start Saving Now →